NL8302087A - Pyridazinonverbindingen, werkwijze voor de bereiding hiervan en de toepassing als geneesmiddel. - Google Patents

Pyridazinonverbindingen, werkwijze voor de bereiding hiervan en de toepassing als geneesmiddel. Download PDF

Info

Publication number
NL8302087A
NL8302087A NL8302087A NL8302087A NL8302087A NL 8302087 A NL8302087 A NL 8302087A NL 8302087 A NL8302087 A NL 8302087A NL 8302087 A NL8302087 A NL 8302087A NL 8302087 A NL8302087 A NL 8302087A
Authority
NL
Netherlands
Prior art keywords
pyridazinone
compounds
choh
formula
compounds according
Prior art date
Application number
NL8302087A
Other languages
English (en)
Dutch (nl)
Original Assignee
Thea Therapeutique & Applicat
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thea Therapeutique & Applicat filed Critical Thea Therapeutique & Applicat
Publication of NL8302087A publication Critical patent/NL8302087A/nl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32Oxygen atoms
    • C07D307/33Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/04Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NL8302087A 1982-06-18 1983-06-11 Pyridazinonverbindingen, werkwijze voor de bereiding hiervan en de toepassing als geneesmiddel. NL8302087A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8210630 1982-06-18
FR8210630A FR2528837A1 (fr) 1982-06-18 1982-06-18 Arylacetyl butanolides et leurs derives pyridazinones utilisables comme medicaments, et procedes pour leur fabrication

Publications (1)

Publication Number Publication Date
NL8302087A true NL8302087A (nl) 1984-01-16

Family

ID=9275129

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8302087A NL8302087A (nl) 1982-06-18 1983-06-11 Pyridazinonverbindingen, werkwijze voor de bereiding hiervan en de toepassing als geneesmiddel.

Country Status (10)

Country Link
JP (1) JPS5910571A (de)
KR (1) KR860001339B1 (de)
BE (1) BE897085A (de)
CH (1) CH657125B (de)
DE (1) DE3321772A1 (de)
FR (1) FR2528837A1 (de)
GB (1) GB2122195A (de)
GR (1) GR78284B (de)
IT (1) IT1194281B (de)
NL (1) NL8302087A (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4666902A (en) * 1983-06-20 1987-05-19 Cassella Aktiengesellschaft Tetrahydropyridazinone derivatives, processes for their preparation and their use
EP0210530A1 (de) * 1985-07-27 1987-02-04 MERCK PATENT GmbH 6-Arylalkenylpyridazinone
JPS63220512A (ja) * 1987-03-09 1988-09-13 松下電器産業株式会社 電解コンデンサ用電極箔
JPH04100106U (de) * 1991-02-12 1992-08-28
JPH0776050B2 (ja) * 1991-07-25 1995-08-16 実 近藤 ワークの移送装置

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2304977A1 (de) * 1973-02-01 1974-08-08 Basf Ag Neue dihydropyridazinone

Also Published As

Publication number Publication date
CH657125B (de) 1986-08-15
KR860001339B1 (ko) 1986-09-15
IT1194281B (it) 1988-09-14
DE3321772A1 (de) 1983-12-22
IT8321684A0 (it) 1983-06-17
FR2528837A1 (fr) 1983-12-23
JPS5910571A (ja) 1984-01-20
FR2528837B1 (de) 1984-12-07
GR78284B (de) 1984-09-26
BE897085A (fr) 1983-12-19
GB8316516D0 (en) 1983-07-20
KR840005105A (ko) 1984-11-03
GB2122195A (en) 1984-01-11

Similar Documents

Publication Publication Date Title
US5366997A (en) Oxygen substituted derivatives of nucleophile-nitric oxide adducts as nitric oxide donor prodrugs
EP0092458A2 (de) Imidazo(1,2-a)Pyridinderivate, ihre Herstellung und therapeutische Verwendung
JPS6016934B2 (ja) フッ素含有1,4−ジヒドロピリジン化合物およびその製造方法
LU87297A1 (fr) 1,4-dihydropyridines,leur procede de preparation et leur application comme medicaments
EP0138721B1 (de) Benzensulfonyllactame, Verfahren zu ihrer Herstellung und ihre Anwendung als wirksame Bestandteile in pharmazeutischen Zusammensetzungen
NL8302087A (nl) Pyridazinonverbindingen, werkwijze voor de bereiding hiervan en de toepassing als geneesmiddel.
DK158460B (da) Analogifremgangsmaade til fremstilling af substituerede oxocarboxylsyrer
JPH0411547B2 (de)
JPS63107979A (ja) 新規化合物、その製法及びそれを含む医薬組成物
US4512994A (en) Long-acting theophylline in medicinal form
FR2509725A1 (fr) (hydroxyalkyl)phenylsulfures, leurs procedes de preparation et compositions pharmaceutiques les contenant
CH661271A5 (fr) Derives de piperazine et d'homopiperazine, leurs procedes de preparation et les compositions pharmaceutiques les renfermant.
CA2296725C (fr) Polyhydroxybutylpyrazines, leur preparation et les medicaments les contenant
FR2499853A1 (fr) Agents cardiotoniques, a base de derives du 5-phenylthiazole et composition pharmaceutique contenant un tel agent
JPS5943460B2 (ja) 2−アミノ−6−ジアルキルアミノジヒドロピリジンの製造方法
EP0035945B1 (de) Acylguanidine, Harnstoffe und substituierte Harnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
NL8301269A (nl) Werkwijze ter bereiding van nieuwe furanderivaten.
EP0035619B1 (de) 3-Amino-(1H,3H)-2,4-chinazolindionderivate
JPS5911584B2 (ja) 2,6−ジアミノ−ジヒドロピリジン類の製造法
JPS5831352B2 (ja) 新規なインド−ル誘導体、その製造方法及び医薬としての使用
FR2601009A1 (fr) Derives de cyclohexanone
US3981882A (en) Process for preparing 4-aryl of hetero-6-amino-3,4-dihydropyrid-2-one-3,5-dicarboxylic acid ester
JPS6258349B2 (de)
RU2052459C1 (ru) Производное хромона, обладающее гипотензивной и аналептической активностью
JPS60188373A (ja) 新規ヒダントイン誘導体及び該化合物を有効成分として含有する医薬組成物

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BV The patent application has lapsed